Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
1. Executive Summary |
2. Global Cardiac Markers Market Introduction |
2.1. Global Cardiac Markers Market – Taxonomy |
2.2. Global Cardiac Markers Market –Definitions |
2.2.1. By Test Type |
2.2.2. By Type of Testing |
2.2.3. By Region |
3. Global Cardiac Markers Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Global Cardiac Markers Market Dynamic Factors - Impact Analysis |
3.6. Global Cardiac Markers Market – Competition Landscape |
4. Global Cardiac Markers Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 |
4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, US$ Mn) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Cardiac Markers Market, By Test Type, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, US$ Mn) |
5.1. NT-proBNP Test |
5.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, US$ Mn) |
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Troponin I & T |
5.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, US$ Mn) |
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. GDF-15 |
5.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, US$ Mn) |
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. hsCRP |
5.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, US$ Mn) |
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
5.5. Others |
5.5.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, US$ Mn) |
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.5.3. Market Opportunity Analysis |
6. Global Cardiac Markers Market, By Type of Testing, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, US$ Mn) |
6.1. Laboratory Testing |
6.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, US$ Mn) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Point of Care Testing |
6.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, US$ Mn) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
7. Global Cardiac Markers Market Forecast, By Region, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, US$ Mn) |
7.1. North America |
7.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, US$ Mn) |
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Europe |
7.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, US$ Mn) |
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Asia-Pacific |
7.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, US$ Mn) |
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Latin America |
7.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, US$ Mn) |
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Middle East and Africa |
7.5.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, US$ Mn) |
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
7.6. Global Cardiac Markers Market - Opportunity Analysis Index, By Test Type, Type of Testing, and Region, 2022 - 2028 |
8. North America Cardiac Markers Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, US$ Mn) |
8.1. Test Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%) |
8.1.1. NT-proBNP Test |
8.1.2. Troponin I & T |
8.1.3. GDF-15 |
8.1.4. CK-MB |
8.1.5. hsCRP |
8.1.6. Others |
8.2. Type of Testing Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%) |
8.2.1. Laboratory Testing |
8.2.2. Point of Care Testing |
8.3. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (US$ Mn) Y-o-Y Growth (%) and Market Share (%) |
8.3.1. USA |
8.3.2. Canada |
8.4. North America Cardiac Markers Market - Opportunity Analysis Index, By Test Type, Type of Testing, and Country, 2022 - 2028 |
8.5. North America Cardiac Markers Market Dynamics – Trends |
9. Europe Cardiac Markers Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, US$ Mn) |
9.1. Test Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%) |
9.1.1. NT-proBNP Test |
9.1.2. Troponin I & T |
9.1.3. GDF-15 |
9.1.4. CK-MB |
9.1.5. hsCRP |
9.1.6. Others |
9.2. Type of Testing Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%) |
9.2.1. Laboratory Testing |
9.2.2. Point of Care Testing |
9.3. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (US$ Mn) Y-o-Y Growth (%) and Market Share (%) |
9.3.1. Germany |
9.3.2. UK |
9.3.3. France |
9.3.4. Spain |
9.3.5. Italy |
9.3.6. Russia |
9.3.7. Rest of Europe |
9.4. Europe Cardiac Markers Market - Opportunity Analysis Index, By Test Type, Type of Testing, and Country, 2022 - 2028 |
9.5. Europe Cardiac Markers Market Dynamics – Trends |
10. Asia-Pacific Cardiac Markers Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, US$ Mn) |
10.1. Test Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%) |
10.1.1. NT-proBNP Test |
10.1.2. Troponin I & T |
10.1.3. GDF-15 |
10.1.4. CK-MB |
10.1.5. hsCRP |
10.1.6. Others |
10.2. Type of Testing Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%) |
10.2.1. Laboratory Testing |
10.2.2. Point of Care Testing |
10.3. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (US$ Mn) Y-o-Y Growth (%) and Market Share (%) |
10.3.1. Japan |
10.3.2. China |
10.3.3. India |
10.3.4. ASEAN |
10.3.5. Australia & New Zealand |
10.3.6. Rest of Asia-Pacific |
10.4. Asia-Pacific Cardiac Markers Market - Opportunity Analysis Index, By Test Type, Type of Testing, and Country, 2022 - 2028 |
10.5. Asia-Pacific Cardiac Markers Market Dynamics – Trends |
11. Latin America Cardiac Markers Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, US$ Mn) |
11.1. Test Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%) |
11.1.1. NT-proBNP Test |
11.1.2. Troponin I & T |
11.1.3. GDF-15 |
11.1.4. CK-MB |
11.1.5. hsCRP |
11.1.6. Others |
11.2. Type of Testing Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%) |
11.2.1. Laboratory Testing |
11.2.2. Point of Care Testing |
11.3. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (US$ Mn) Y-o-Y Growth (%) and Market Share (%) |
11.3.1. Brazil |
11.3.2. Mexico |
11.3.3. Argentina |
11.3.4. Rest of Latin America |
11.4. Latin America Cardiac Markers Market - Opportunity Analysis Index, By Test Type, Type of Testing, and Country, 2022 - 2028 |
11.5. Latin America Cardiac Markers Market Dynamics – Trends |
12. Middle East and Africa Cardiac Markers Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, US$ Mn) |
12.1. Test Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%) |
12.1.1. NT-proBNP Test |
12.1.2. Troponin I & T |
12.1.3. GDF-15 |
12.1.4. CK-MB |
12.1.5. hsCRP |
12.1.6. Others |
12.2. Type of Testing Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%) |
12.2.1. Laboratory Testing |
12.2.2. Point of Care Testing |
12.3. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (US$ Mn) Y-o-Y Growth (%) and Market Share (%) |
12.3.1. Gulf Cooperation Council (GCC) Countries |
12.3.2. Israel |
12.3.3. South Africa |
12.3.4. Rest of MEA |
12.4. MEA Cardiac Markers Market - Opportunity Analysis Index, By Test Type, Type of Testing, and Country, 2022 - 2028 |
12.5. MEA Cardiac Markers Market Dynamics – Trends |
13. Competition Landscape |
13.1. Strategic Dashboard of Top Market Players |
13.2. Company Profiles (Introduction, Financial Analysis, Test Type & Service Offerings, Key Developments, Strategies, and SWOT Analysis) |
13.2.1. F. Hoffman-LA Roche |
13.2.2. Abbott Laboratories |
13.2.3. Siemens |
13.2.4. Danaher Corporation |
13.2.5. Biomerieux |
13.2.6. Ortho Clinical Diagnostics |
13.2.7. Randox Laboratories |
14. Research Methodology |
15. Key Assumptions and Acronyms |
Download Free Sample Report
2021 is the base year and 2028 is the forecast year.
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
Key Market Players